Literature DB >> 34137848

On the road to optimized BTK inhibition in CLL.

Lukáš Smolej1.   

Abstract

Entities:  

Year:  2021        PMID： 34137848     DOI： 10.1182/blood.2021011462

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies.

Authors:  Isha Kapoor; Juraj Bodo; Brian T Hill; Alexandru Almasan
Journal:  Cell Death Dis       Date:  2021-11-08       Impact factor: 8.469

Review 2.  Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance.

Authors:  Frédérique St-Pierre; Shuo Ma
Journal:  Blood Lymphat Cancer       Date:  2022-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.